Proteome	O
analysis	O
of	O
NIH3T3	B-Cell
cells	I-Cell
transformed	O
by	O
activated	O
Galpha12	O
:	O
regulation	O
of	O
leukemia	B-Cancer
-	O
associated	O
protein	O
SET	O
.	O

Galpha	O
(	O
12	O
)	O
,	O
the	O
alpha	O
-	O
subunit	O
of	O
the	O
G12	O
family	O
of	O
heterotrimeric	O
G	O
proteins	O
is	O
involved	O
in	O
the	O
regulation	O
of	O
cell	B-Cell
proliferation	O
and	O
neoplastic	B-Cancer
transformation	O
.	O

GTPase	O
-	O
deficient	O
,	O
constitutively	O
activated	O
mutant	O
of	O
Galpha	O
(	O
12	O
)	O
(	O
Galpha	O
(	O
12	O
)	O
Q229L	O
or	O
Galpha	O
(	O
12	O
)	O
QL	O
)	O
has	O
been	O
previously	O
shown	O
to	O
induce	O
oncogenic	O
transformation	O
of	O
NIH3T3	B-Cell
cells	I-Cell
promoting	O
serum	B-Organism_substance
-	O
and	O
anchorage	O
-	O
independent	O
growth	O
.	O

Reduced	O
growth	O
-	O
factor	O
dependent	O
,	O
autonomous	O
cell	B-Cell
growth	O
forms	O
a	O
critical	O
defining	O
point	O
at	O
which	O
a	O
normal	O
cell	B-Cell
turns	O
into	O
an	O
oncogenic	O
one	O
.	O

To	O
identify	O
the	O
underlying	O
mechanism	O
involved	O
in	O
such	O
growth	O
-	O
factor	O
/	O
serum	B-Organism_substance
independent	O
growth	O
of	O
Galpha	O
(	O
12	O
)	O
QL	O
-	O
transformed	O
NIH3T3	B-Cell
,	O
we	O
carried	O
out	O
a	O
two	O
-	O
dimensional	O
differential	O
proteome	O
analysis	O
of	O
Galpha	O
(	O
12	O
)	O
QL	O
-	O
transformed	O
NIH3T3	B-Cell
cells	I-Cell
and	O
cells	B-Cell
expressing	O
vector	O
control	O
.	O

This	O
analysis	O
revealed	O
a	O
total	O
of	O
22	O
protein	O
-	O
spots	O
whose	O
expression	O
was	O
altered	O
by	O
more	O
than	O
3	O
-	O
folds	O
.	O

Two	O
of	O
these	O
spots	O
were	O
identified	O
by	O
MALDI	O
-	O
MS	O
analysis	O
as	O
proliferating	O
cell	O
nuclear	O
antigen	O
(	O
PCNA	O
)	O
and	O
myeloid	B-Cancer
-	I-Cancer
leukemia	I-Cancer
-	O
associated	O
SET	O
protein	O
.	O

The	O
increased	O
expressions	O
of	O
these	O
proteins	O
in	O
Galpha	B-Cell
(	I-Cell
12	I-Cell
)	I-Cell
QL	I-Cell
cells	I-Cell
were	O
validated	O
by	O
immunoblot	O
analysis	O
.	O

Furthermore	O
,	O
transient	O
transfection	O
studies	O
with	O
NIH3T3	B-Cell
cells	I-Cell
indicated	O
that	O
the	O
expression	O
of	O
activated	O
Galpha	O
(	O
12	O
)	O
readily	O
increased	O
the	O
expression	O
of	O
SET	O
protein	O
by	O
24	O
h	O
.	O

As	O
SET	O
has	O
been	O
previously	O
reported	O
to	O
be	O
an	O
inhibitor	O
of	O
phosphatase	O
PP2A	O
,	O
the	O
nuclear	B-Cellular_component
phosphatase	O
activity	O
was	O
monitored	O
in	O
cells	B-Cell
expressing	O
activated	O
Galpha	O
(	O
12	O
)	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
nuclear	B-Cellular_component
phosphatase	O
activity	O
is	O
inhibited	O
by	O
greater	O
than	O
50	O
%	O
in	O
Galpha	B-Cell
(	I-Cell
12	I-Cell
)	I-Cell
QL	I-Cell
cells	I-Cell
compared	O
to	O
vector	O
control	O
cells	B-Cell
.	O

Thus	O
,	O
our	O
results	O
from	O
differential	O
proteome	O
analysis	O
presented	O
here	O
report	O
for	O
the	O
first	O
time	O
a	O
role	O
for	O
SET	O
in	O
Galpha	O
(	O
12	O
)	O
-	O
mediated	O
signaling	O
pathways	O
and	O
a	O
role	O
for	O
Galpha	O
(	O
12	O
)	O
in	O
the	O
regulation	O
of	O
the	O
leukemia	B-Cancer
-	O
associated	O
SET	O
-	O
protein	O
expression	O
.	O

